retatrutide study results phase 3 trials Looking forward to when #retatrutide's trial will become available. There are Phase III retatrutide study demonstrates

I look forward to seeing more results in the coming weeks. 5 WEEKS Incredible

Its also important to take a multivitamin supplement while taking orlistat, as the drug can block the absorption of fat-soluble vitamins

These factors support GLP-1 use in diabetes and obesity treatment

NICE approved semaglutide (Wegovy) for weight management in specialist NHS weight management services in 2023 (TA875), but availability is limited to patients with: BMI 35 kg/m with at least one weight-related comorbidity, or BMI 30 kg/m with exceptional circumstances Lower BMI thresholds apply for people from some minority ethnic groups (typically 27.5 kg/m) Participation in a specialist weight management programme Treatment limited to a maximum of 2 years Access varies by region due to local integrated care board (ICB) implementation decisions and limited NHS specialist service capacity